Concepedia

Author

Antònia Sampol

Hospital Universitario Son EspasesORCID

Also Known As

A Bermdez, A Sampol, A. SAMPOL, A. Sampol, Ana P. Gonzalez, Ana Pilar González, Antonia Sampol, Antònia Sampol, Christelle Ferrá, J M Pascual Izuel

174

Publications

2.2K

Citations

24

H-Index

48

Concepts

All Affiliations

Hospital Universitario Son EspasesHospital de Sant PauHospital Clínic de BarcelonaHospital Clínico Universitario de ValenciaHospital General Universitario Gregorio Marañón
AS

About

Antònia Sampol is an author at Hospital Universitario Son Espases specializing in medicine, hematology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

9

185

2

Health Sciences

6

6

116

3

Blood Transplantation

3

3

62

4

Cellular Therapies

1

1

24

5

Diagnostic Sciences

1

1

19

Antònia Sampol

×

44

Publications

1.6K

Citations

23

H-Index

YearCitations

Sustained Remissions of High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome After Reduced-Intensity Conditioning Allogeneic Hematopoietic Transplantation: Chronic Graft-Versus-Host Disease Is the Strongest Factor Improving Survival

David Valcárcel, Rodrigo Martino, Dolores Caballero,

Journal of Clinical Oncology

2007

231

Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party

Thomas Daikeler, Myriam Labopin, Massimo Di Gioia,

Blood

2011

168

Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registry

Bassam Alchi, David Jayne, Myriam Labopin,

Lupus

2012

90

Reduced intensity conditioning HLA identical sibling donor allogeneic stem cell transplantation for patients with follicular lymphoma: long-term follow-up from two prospective multicenter trials

José Luís Piñana, Rodrigo Martino, Jorge Gayoso,

Haematologica

2010

67

Thrombopoietin Receptor Agonists for Severe Thrombocytopenia after Allogeneic Stem Cell Transplantation: Experience of the Spanish Group of Hematopoietic Stem Cell Transplant

Leyre Bento, José María Bastida, Irene García‐Cadenas,

Biology of Blood and Marrow Transplantation

2019

63

Outcome of Second Allogeneic Hematopoietic Cell Transplantation after Relapse of Myeloid Malignancies following Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort on Behalf of the Grupo Español de Trasplante Hematopoyetico

Guillermo Ortí, Jaime Sanz, Arancha Bermúdez,

Biology of Blood and Marrow Transplantation

2015

61

European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol

Álex Bataller, Ana Garrido, Francesca Guijarro,

Blood Advances

2021

54

Lenalidomide and dexamethasone maintenance with or without ixazomib, tailored by residual disease status in myeloma

Laura Rosiñol, Albert Oriol, Rafael Ríos,

Blood

2023

50

Alemtuzumab as Treatment of Steroid-Refractory Acute Graft-versus-Host Disease: Results of a Phase II Study

Carmen Martı́nez, Carlos Solano, Christelle Ferrá,

Biology of Blood and Marrow Transplantation

2009

49

Prospective Randomized Study Comparing Myeloablative Unrelated Umbilical Cord Blood Transplantation versus HLA-Haploidentical Related Stem Cell Transplantation for Adults with Hematologic Malignancies

Jaime Sanz, Juan Montoro, Carlos Solano,

Biology of Blood and Marrow Transplantation

2019

49

Page 1